SCHEMBL4145436

SCHEMBL4145436

CN(C(=O)N(C(=O)OCc1ccccc1)C(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
RORC P51449 5/20 0.33
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
PPARG P37231 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
NR1H4 Q96RI1 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
CXCR2 P25025 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
RAB9A P51151 1/20 0.31
ALDH1A1 P00352 1/20 0.30
MLYCD O95822 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637560 0.91 PPARG (0.34) RORCLMNAMAPTTSHRMAPK1
SCHEMBL4156860 0.87 LMNA (0.33) TDP1RORCLMNAMAPTTSHR
SCHEMBL4142557 0.86 RORC (0.33) TDP1RORCLMNAMAPTTSHR
SCHEMBL4150962 0.84 TDP1 (0.37) TDP1RORCLMNAMAPTTSHR
SCHEMBL4159030 0.83 TDP1 (0.45) TDP1RORCLMNAMAPTTSHR
SCHEMBL4142611 0.82 RORC (0.35) TDP1RORCLMNAMAPTTSHR
SCHEMBL4144806 0.82 RORC (0.35) TDP1RORCLMNAMAPTTSHR
SCHEMBL4154435 0.79 RORC (0.36) TDP1RORCLMNAMAPTTSHR
SCHEMBL4157996 0.78 RORC (0.35) TDP1RORCLMNAMAPTTSHR
SCHEMBL5314242 0.78 TDP1 (0.36) TDP1LMNAMAPTTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 TDP1 1690/4885RORC 4448/4885LMNA 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.